Ixazomib Citrate (1201902-80-8)
![quality [#varpname#] factory](/images/load_icon.gif){kind=icon}
Product:
Ixazomib
Description:
CAS: 1201902-80-8; Ixazomib manufacturer; Ixazomib API; Ixazomib proteasome inhibitor; Anti-Tumor
Category:
Anti-Tumor
In-stock:
In Stock
Payment Method:
L/C, T/T
Shipping Method:
AIR, Express
Specifications
CAS:
1201902-80-8
Specification:
CP, EP, In-house, As Required
M.F.:
C20H23BCl2N2O9
M.W.:
517.12
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Ixazomib Citrate 1201902-80-8
,Ixazomib API 1201902-80-8
,Ixazomib proteasome inhibitor
Introduction
Ixazomib Citrate (1201902-80-8)
Ixazomib citrate is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anti-cancer agent that is used for treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate obtains higher pharmacokinetics, efficacy, and anticancer activity.
| Product Name: | Ixazomib Citrate |
| CAS No.: | 1201902-80-8 |
| Assay: | 98% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C20H23BCl2N2O9 |
| Molecular Weight: | 517.12 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Related Products
2-(2,5-dichlorobenzamido)acetic acid (667403-46-5)
CAS: 667403-46-5; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9)
CAS: 179324-87-9; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
| Image | Part # | Description | |
|---|---|---|---|
|
|
2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) |
CAS: 667403-46-5; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
|
|
|
|
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) |
CAS: 179324-87-9; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
|
Send RFQ
Stock:
In Stock
MOQ:
